Updated Phase 2 CRDF-004 data to be presented during ASCO 2026 rapid oral session on June 2, 2026; investor webcast scheduled for June 3, 2026 at 8:30 am ET to review the dataSAN DIEGO, Calif., May 21 ...
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...
Pfizer (PFE) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent ...
U.S. Department of War through the Defense Logistics Agency has awarded Flash Metals Texas, ...
Please provide your email address to receive an email when new articles are posted on . One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results ...
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's DiseaseTreatment of ...
Phase 2 of the project will manage up to 2,900t of waste daily, supporting energy generation and resource recovery.